Business Description
InspireMD Inc
NAICS : 339112
SIC : 3841
ISIN : US45779A8615
Description
Financial Strength
6/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Cash-To-Debt | 24.47 | |||||
Equity-to-Asset | 0.83 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.08 | |||||
Interest Coverage | N/A | |||||
Piotroski F-Score | 5/9 | |||||
Altman Z-Score | -3.32 | |||||
Beneish M-Score | -2.26 | |||||
WACC vs ROIC |
Growth Rank
2/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -46.2 | |||||
3-Year EBITDA Growth Rate | 49.7 | |||||
3-Year EPS without NRI Growth Rate | 51 | |||||
3-Year FCF Growth Rate | 51.5 | |||||
3-Year Book Growth Rate | -21.2 |
Momentum Rank
10/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
5-Day RSI | 55.51 | |||||
9-Day RSI | 45.94 | |||||
14-Day RSI | 42.53 | |||||
6-1 Month Momentum % | -38.44 | |||||
12-1 Month Momentum % | 75.89 |
Liquidity Ratio
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Current Ratio | 7.34 | |||||
Quick Ratio | 6.99 | |||||
Cash Ratio | 6.48 | |||||
Days Inventory | 148.71 | |||||
Days Sales Outstanding | 79.65 | |||||
Days Payable | 59.31 |
Dividend & Buy Back
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -88.1 | |||||
Shareholder Yield % | 0.06 |
Profitability Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
Gross Margin % | 29.12 | |||||
Operating Margin % | -340.74 | |||||
Net Margin % | -320.97 | |||||
FCF Margin % | -270.36 | |||||
ROE % | -62.09 | |||||
ROA % | -50.84 | |||||
ROIC % | -397.54 | |||||
ROC (Joel Greenblatt) % | -875.92 | |||||
ROCE % | -61.86 |
GF Value Rank
1/10
Name | Current | Vs Industry | Vs History | |||
---|---|---|---|---|---|---|
PS Ratio | 6.11 | |||||
PB Ratio | 1.11 | |||||
Price-to-Tangible-Book | 1.15 | |||||
EV-to-EBIT | -0.46 | |||||
EV-to-EBITDA | -0.46 | |||||
EV-to-Revenue | 1.56 | |||||
EV-to-Forward-Revenue | 2.19 | |||||
EV-to-FCF | -0.58 | |||||
Price-to-Net-Current-Asset-Value | 1.26 | |||||
Price-to-Net-Cash | 1.48 | |||||
Earnings Yield (Greenblatt) % | -217.39 | |||||
FCF Yield % | -35.59 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Annualized Return % Â
Total Annual Return % Â
InspireMD Inc Executives
DetailsAnalyst Estimate
Key Statistics
Name | Value | ||
---|---|---|---|
Revenue (TTM) (Mil €) | 5.752 | ||
EPS (TTM) (€) | -0.977 | ||
Beta | -0.21 | ||
Volatility % | 90.38 | ||
14-Day RSI | 42.53 | ||
14-Day ATR (€) | 0.062098 | ||
20-Day SMA (€) | 1.961 | ||
12-1 Month Momentum % | 75.89 | ||
52-Week Range (€) | 1.18 - 3.42 | ||
Shares Outstanding (Mil) | 23.42 |
Piotroski F-Score Details
Component | Result | ||
---|---|---|---|
Piotroski F-Score | 5 | ||
Positive ROA | |||
Positive CFROA | |||
Higher ROA yoy | |||
CFROA > ROA | |||
Lower Leverage yoy | |||
Higher Current Ratio yoy | |||
Less Shares Outstanding yoy | |||
Higher Gross Margin yoy | |||
Higher Asset Turnover yoy |
InspireMD Inc Filings
Filing Date | Document Date | Form | ||
---|---|---|---|---|
No Filing Data |
InspireMD Inc Stock Events
Event | Date | Price(€) | ||
---|---|---|---|---|
No Event Data |
InspireMD Inc Frequently Asked Questions
What is InspireMD Inc(FRA:II2)'s stock price today?
When is next earnings date of InspireMD Inc(FRA:II2)?
Does InspireMD Inc(FRA:II2) pay dividends? If so, how much?
Press Release
Subject | Date | |||
---|---|---|---|---|
No Press Release |